“The FDA turns a blind eye. If your market [share] is big enough, then you get leeway,” one former inspector said.
“The FDA turns a blind eye. If your market [share] is big enough, then you get leeway,” one former inspector said.
Help us gain our following back
Follow
Retweet
Repeat
Join the park side
@altyellonatpark.org
Help us gain our following back
Follow
Retweet
Repeat
Join the park side
@altyellonatpark.org